Rainer Haemmerle
ED, Manufacturing
Boehringer Ingelheim Biopharmaceuticals GmbH

Details:

  • Exploring how strategic partnerships accelerate the adoption of new manufacturing capabilities and technologies
  • Highlighting how collaboration enables agility, from early development through commercial scale
  • Discussing how flexible partnership models can help biopharma companies navigate shifting market and regulatory pressures